These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4173466)

  • 21. Intermittent chemotherapy.
    Tubercle; 1967 Mar; 48(1):58-61. PubMed ID: 4166513
    [No Abstract]   [Full Text] [Related]  

  • 22. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Second report.
    Lancet; 1973 Jun; 1(7816):1331-8. PubMed ID: 4122738
    [No Abstract]   [Full Text] [Related]  

  • 23. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
    Tubercle; 1973 Jun; 54(2):99-129. PubMed ID: 4203162
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison between high daily dosage of isoniazid in divided doses and low daily dosage in a single dose in triple-drug regimens.
    Tubercle; 1968 Jun; 49(2):170-9. PubMed ID: 5664315
    [No Abstract]   [Full Text] [Related]  

  • 25. Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East Africa--second report of fifth investigation. Aco-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.
    Tubercle; 1970 Dec; 51(4):353-8. PubMed ID: 4099649
    [No Abstract]   [Full Text] [Related]  

  • 26. A pilot study of two regimens of intermittent thiacetazone plus isoniazid in the treatment of pulmonary tuberculosis in East Africa.
    Tubercle; 1974 Sep; 55(3):211-21. PubMed ID: 4143452
    [No Abstract]   [Full Text] [Related]  

  • 27. Ethambutol-isoniazid versus PAS-isoniazid in original treatment of pulmonary tuberculosis.
    Bobrowitz ID; Robins DE
    Am Rev Respir Dis; 1967 Sep; 96(3):428-38. PubMed ID: 6039097
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1972 May; 1(7760):1079-85. PubMed ID: 4112569
    [No Abstract]   [Full Text] [Related]  

  • 29. The results from twelve to thirty-six months in patients submitted to two studies of primary chemotherapy for pulmonary tuberculosis in East Africa.
    Tubercle; 1969 Sep; 50(3):233-56. PubMed ID: 4186789
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of acceptable and adequate outpatient treatment on the length of hospitalization and on readmission for relapse or reactivation of pulmonary tuberculosis.
    Curry FJ
    Chest; 1973 Apr; 63(4):536-46. PubMed ID: 4633013
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to treatment with isoniazid plus PAS of tuberculous patients with primary isoniazid resistance.
    Tripathy SP; Menon NK; Mitchison DA; Narayana AS; Somasundaram PA; Stott H; Velu S
    Tubercle; 1969 Sep; 50(3):257-68. PubMed ID: 4981496
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled clinical trial of the drug treatment of new cases of pulmonary tuberculosis.
    Böszörményi M; Schweiger O
    Scand J Respir Dis Suppl; 1968; 65():189-93. PubMed ID: 4978460
    [No Abstract]   [Full Text] [Related]  

  • 33. A controlled clinical trial of the role of thiacetazone-containing regimens in the treatment of pulmonary tuberculosis in Singapore: second report.
    Tubercle; 1974 Dec; 55(4):251-60. PubMed ID: 4143454
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

  • 35. Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration.
    Okwera A; Whalen C; Byekwaso F; Vjecha M; Johnson J; Huebner R; Mugerwa R; Ellner J
    Lancet; 1994 Nov; 344(8933):1323-8. PubMed ID: 7526098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-phase chemotherapy of pulmonary tuberculosis.
    Bhatia JL; Thind GS
    J Indian Med Assoc; 1969 Nov; 53(9):443-9. PubMed ID: 4189572
    [No Abstract]   [Full Text] [Related]  

  • 37. A two-year follow-up of patients with quiescent pulmonary tuberculosis following a year of chemotherapy with an intermittent (twice-weekly) regimen of isoniazid plus streptomycin or a daily regimen of isoniazid plus PAS.
    Nazareth O; Devadatta S; Evans C; Fox W; Janardhanam B; Menon NK; Radhakrishna S; Ramakrishnan CV; Stott H; Tripathy SP; Velu S
    Tubercle; 1966 Jun; 47(2):178-89. PubMed ID: 5963586
    [No Abstract]   [Full Text] [Related]  

  • 38. Thiacetazone in pulmonary tuberculosis with reference to its clinical intolerance.
    Sen PK; Sen NN; Saha JR; Paul NB; Prodhan PK
    Indian J Med Res; 1970 Aug; 58(8):1002-11. PubMed ID: 4099710
    [No Abstract]   [Full Text] [Related]  

  • 39. PAS.
    Tubercle; 1973 Jun; 54(2):165-7. PubMed ID: 4128919
    [No Abstract]   [Full Text] [Related]  

  • 40. Streptomycin plus PAS plus pyrazinamide in the retreatment of pulmonary tuberxulisis in East Africa.
    Tubercle; 1971 Sep; 52(3):191-8. PubMed ID: 4938216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.